ADELA CASTILLEJO CASTILLO-rekin lankidetzan egindako argitalpenak (8)

2018

  1. A label free disposable device for rapid isolation of rare tumor cells from blood by ultrasounds

    Micromachines, Vol. 9, Núm. 3

2016

  1. Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

    BMC Cancer, Vol. 16, Núm. 1

2010

  1. Biallelic MYH germline mutations as cause of Muir-Torre syndrome

    Familial Cancer, Vol. 9, Núm. 2, pp. 151-154

  2. Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: A pilot study

    Clinical and Translational Oncology, Vol. 12, Núm. 2, pp. 142-147

2009

  1. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis

    International Journal of Cancer, Vol. 124, Núm. 3, pp. 608-613

  2. The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: A case-control study

    BMC Cancer, Vol. 9

  3. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: A case-control study

    BMC Cancer, Vol. 9

  4. Utility of p16 immunohistochemistry for the identification of Lynch syndrome

    Clinical Cancer Research, Vol. 15, Núm. 9, pp. 3156-3162